Cargando…
HRas and Myc synergistically induce cell cycle progression and apoptosis of murine cardiomyocytes
AIM: Adult mammalian cardiomyocytes are incapable of significant proliferation, limiting regeneration after myocardial injury. Overexpression of the transcription factor Myc has been shown to drive proliferation in the adult mouse heart, but only when combined with Cyclin T1. As constitutive HRas ac...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630352/ https://www.ncbi.nlm.nih.gov/pubmed/36337898 http://dx.doi.org/10.3389/fcvm.2022.948281 |
_version_ | 1784823584169918464 |
---|---|
author | Boikova, Aleksandra Bywater, Megan J. Quaife-Ryan, Gregory A. Straube, Jasmin Thompson, Lucy Ascanelli, Camilla Littlewood, Trevor D. Evan, Gerard I. Hudson, James E. Wilson, Catherine H. |
author_facet | Boikova, Aleksandra Bywater, Megan J. Quaife-Ryan, Gregory A. Straube, Jasmin Thompson, Lucy Ascanelli, Camilla Littlewood, Trevor D. Evan, Gerard I. Hudson, James E. Wilson, Catherine H. |
author_sort | Boikova, Aleksandra |
collection | PubMed |
description | AIM: Adult mammalian cardiomyocytes are incapable of significant proliferation, limiting regeneration after myocardial injury. Overexpression of the transcription factor Myc has been shown to drive proliferation in the adult mouse heart, but only when combined with Cyclin T1. As constitutive HRas activity has been shown to stabilise Cyclin T1 in vivo, we aimed to establish whether Myc and HRas could also act cooperatively to induce proliferation in adult mammalian cardiomyocytes in vivo. METHODS AND RESULTS: Using a genetically modified mouse model, we confirmed that constitutive HRas activity (HRas(G)(12)(V)) increased Cyclin T1 expression. HRas(G)(12)(V) and constitutive Myc expression together co-operate to drive cell-cycle progression of adult mammalian cardiomyocytes. However, stimulation of endogenous cardiac proliferation by the ectopic expression of HRas(G)(12)(V) and Myc also induced cardiomyocyte death, while Myc and Cyclin T1 expression did not. CONCLUSION: Co-expression of Cyclin T1 and Myc may be a therapeutically tractable approach for cardiomyocyte neo-genesis post injury, while cell death induced by HRas(G)(12)(V) and Myc expression likely limits this option as a regenerative therapeutic target. |
format | Online Article Text |
id | pubmed-9630352 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96303522022-11-04 HRas and Myc synergistically induce cell cycle progression and apoptosis of murine cardiomyocytes Boikova, Aleksandra Bywater, Megan J. Quaife-Ryan, Gregory A. Straube, Jasmin Thompson, Lucy Ascanelli, Camilla Littlewood, Trevor D. Evan, Gerard I. Hudson, James E. Wilson, Catherine H. Front Cardiovasc Med Cardiovascular Medicine AIM: Adult mammalian cardiomyocytes are incapable of significant proliferation, limiting regeneration after myocardial injury. Overexpression of the transcription factor Myc has been shown to drive proliferation in the adult mouse heart, but only when combined with Cyclin T1. As constitutive HRas activity has been shown to stabilise Cyclin T1 in vivo, we aimed to establish whether Myc and HRas could also act cooperatively to induce proliferation in adult mammalian cardiomyocytes in vivo. METHODS AND RESULTS: Using a genetically modified mouse model, we confirmed that constitutive HRas activity (HRas(G)(12)(V)) increased Cyclin T1 expression. HRas(G)(12)(V) and constitutive Myc expression together co-operate to drive cell-cycle progression of adult mammalian cardiomyocytes. However, stimulation of endogenous cardiac proliferation by the ectopic expression of HRas(G)(12)(V) and Myc also induced cardiomyocyte death, while Myc and Cyclin T1 expression did not. CONCLUSION: Co-expression of Cyclin T1 and Myc may be a therapeutically tractable approach for cardiomyocyte neo-genesis post injury, while cell death induced by HRas(G)(12)(V) and Myc expression likely limits this option as a regenerative therapeutic target. Frontiers Media S.A. 2022-10-20 /pmc/articles/PMC9630352/ /pubmed/36337898 http://dx.doi.org/10.3389/fcvm.2022.948281 Text en Copyright © 2022 Boikova, Bywater, Quaife-Ryan, Straube, Thompson, Ascanelli, Littlewood, Evan, Hudson and Wilson. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Boikova, Aleksandra Bywater, Megan J. Quaife-Ryan, Gregory A. Straube, Jasmin Thompson, Lucy Ascanelli, Camilla Littlewood, Trevor D. Evan, Gerard I. Hudson, James E. Wilson, Catherine H. HRas and Myc synergistically induce cell cycle progression and apoptosis of murine cardiomyocytes |
title | HRas and Myc synergistically induce cell cycle progression and apoptosis of murine cardiomyocytes |
title_full | HRas and Myc synergistically induce cell cycle progression and apoptosis of murine cardiomyocytes |
title_fullStr | HRas and Myc synergistically induce cell cycle progression and apoptosis of murine cardiomyocytes |
title_full_unstemmed | HRas and Myc synergistically induce cell cycle progression and apoptosis of murine cardiomyocytes |
title_short | HRas and Myc synergistically induce cell cycle progression and apoptosis of murine cardiomyocytes |
title_sort | hras and myc synergistically induce cell cycle progression and apoptosis of murine cardiomyocytes |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630352/ https://www.ncbi.nlm.nih.gov/pubmed/36337898 http://dx.doi.org/10.3389/fcvm.2022.948281 |
work_keys_str_mv | AT boikovaaleksandra hrasandmycsynergisticallyinducecellcycleprogressionandapoptosisofmurinecardiomyocytes AT bywatermeganj hrasandmycsynergisticallyinducecellcycleprogressionandapoptosisofmurinecardiomyocytes AT quaiferyangregorya hrasandmycsynergisticallyinducecellcycleprogressionandapoptosisofmurinecardiomyocytes AT straubejasmin hrasandmycsynergisticallyinducecellcycleprogressionandapoptosisofmurinecardiomyocytes AT thompsonlucy hrasandmycsynergisticallyinducecellcycleprogressionandapoptosisofmurinecardiomyocytes AT ascanellicamilla hrasandmycsynergisticallyinducecellcycleprogressionandapoptosisofmurinecardiomyocytes AT littlewoodtrevord hrasandmycsynergisticallyinducecellcycleprogressionandapoptosisofmurinecardiomyocytes AT evangerardi hrasandmycsynergisticallyinducecellcycleprogressionandapoptosisofmurinecardiomyocytes AT hudsonjamese hrasandmycsynergisticallyinducecellcycleprogressionandapoptosisofmurinecardiomyocytes AT wilsoncatherineh hrasandmycsynergisticallyinducecellcycleprogressionandapoptosisofmurinecardiomyocytes |